JP Patent

JP6527621B2 — 非転移性去勢抵抗性前立腺癌の治療のための抗アンドロゲン剤

Assigned to アラゴン ファーマシューティカルズ，インコーポレイテッド · Expires 2019-06-05 · 7y expired

What this patent protects

Patent listed against Erleada.

Drugs covered by this patent

Patent Metadata

Patent number
JP6527621B2
Jurisdiction
JP
Classification
—
Expires
2019-06-05
Drug substance claim
No
Drug product claim
No
Assignee
アラゴン ファーマシューティカルズ，インコーポレイテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.